The Most Important Advances in Precision Medicine Being Presented at ASCO 2018

David Spigel, MD

Video Categories: 2018 ASCO Insights, Biomarkers, and Video Library

Dr David Spigel reviews 3 of the most important, practice-changing topics at ASCO 2018: new therapies targeting RET in a number of tumor types, a prognostic biomarker assay to predict whether patients with breast cancer will need adjuvant hormonal therapy or chemotherapy, and the minimum level of PD-L1 positivity required to predict outcomes with immunotherapy in lung cancer.

September 20, 2013

The Pricing Evolution of Personalized Medicines

Grant Lawless discusses the changing landscape of pricing personalized medicines

August 15, 2016

Treatment of Metastatic Liver Tumors

Michael Soulen, MD, talks about the importance of treating metastatic liver tumors.